Zoetis Inc. Files 8-K for January 13, 2025

Ticker: ZTS · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1555280

Zoetis Inc. 8-K Filing Summary
FieldDetail
CompanyZoetis Inc. (ZTS)
Form Type8-K
Filed DateJan 13, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k

Related Tickers: ZTS

TL;DR

Zoetis filed an 8-K on 1/13/25, check for updates.

AI Summary

Zoetis Inc. filed an 8-K on January 13, 2025, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. No specific financial figures or material events beyond the filing itself are detailed in the provided text.

Why It Matters

This filing indicates Zoetis Inc. is providing updates or disclosures to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific financial or operational details that would indicate a high risk.

Key Players & Entities

  • Zoetis Inc. (company) — Registrant
  • January 13, 2025 (date) — Date of report

FAQ

What is the primary purpose of this 8-K filing by Zoetis Inc.?

The primary purpose of this 8-K filing is to report on Regulation FD disclosures and to include financial statements and exhibits, as indicated by the filing's item information.

What is the exact date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is January 13, 2025.

What is Zoetis Inc.'s state of incorporation?

Zoetis Inc. is incorporated in Delaware.

What is the IRS Employer Identification Number for Zoetis Inc.?

The IRS Employer Identification Number for Zoetis Inc. is 46-0696167.

What is the principal executive office address for Zoetis Inc.?

The principal executive office address for Zoetis Inc. is 10 Sylvan Way, Parsippany, New Jersey 07054.

Filing Stats: 495 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-01-13 08:04:57

Key Financial Figures

  • $0.01 — ich registered Common Stock, par value $0.01 per share ZTS New York Stock Exchange

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On January 14, 2025, members of Zoetis Inc.'s executive management team are scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference. A copy of the presentation materials is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Presentation Materials for the 43rd Annual J.P. Morgan Healthcare Conference 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZOETIS INC. Dated: January 13, 2025 By: /s/ Roxanne Lagano Roxanne Lagano Executive Vice President, General Counsel and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.